Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aesthetic device scandal threatens to bring whole industry down with it

This article was originally published in Clinica

Executive Summary

Many products used for aesthetic purposes involve implantation, injection or piercing of the skin. In theory, they come under the medical device definition of causing modification to the anatomy or to a physiological process. Yet most of these products seem to fall into a regulatory no-man’s land. In this investigative feature, Amanda Maxwell exposes a bureaucratic loophole which allows unregulated copies of CE-marked medical devices, or the non-medical use of CE-marked equivalents, to enter the market unchecked

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT095344

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel